Literature DB >> 7477681

Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse.

E M Cornford1, S Hyman, M E Cornford, M Clare-Salzler.   

Abstract

The intracarotid injection method has been utilized to examine blood-brain barrier (BBB) glucose transport in hyperglycemic (4-6 days) mice. In anesthetized mice, Brain Uptake Indices were measured over a range of glucose concentrations from 0.010-50 mmol/l; glucose uptake was found to be saturable and kinetically characterized. The maximal velocity (Vmax) for glucose transport was 989 +/- 214 nmol.min-1.g-1. and the half-saturation constant estimated to be 5.80 +/- 1.38 mmol/l. The unsaturated Permeability Surface area product (PS) is = 171 + 8 microliters.min.-1.g-1. A rabbit polyclonal antiserum to a synthetic peptide encoding the 13 C-terminal amino acids of the human erythrocyte glucose transporter immunocytochemically confirmed the presence of the GLUT1 isoform in non-obese diabetic (NOD) mouse brain capillary endothelia. These studies indicate that a down-regulation of BBB glucose transport occurs in these spontaneously hyperglycemic mice; both BBB glucose permeability (as indicated by PS product) and transporter maximal velocity are reduced (in comparison to normoglycemic CD-1 mice), but the half-saturation constant remains unchanged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477681     DOI: 10.1007/bf00969700

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats.

Authors:  J Jakobsen; M Nedergaard; M Aarslew-Jensen; N H Diemer
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

2.  Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration.

Authors:  R A DeFronzo; R Hendler; N Christensen
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

3.  Regional blood-brain glucose transfer and glucose utilization in chronically hyperglycemic, diabetic rats following acute glycemic normalization.

Authors:  D A Pelligrino; M D Lipa; R F Albrecht
Journal:  J Cereb Blood Flow Metab       Date:  1990-11       Impact factor: 6.200

4.  Downregulation of blood-brain barrier glucose transporter in experimental diabetes.

Authors:  W M Pardridge; D Triguero; C R Farrell
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

5.  Blood-brain barrier glucose transporter mRNA is increased in experimental diabetes mellitus.

Authors:  T B Choi; R J Boado; W M Pardridge
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

Review 6.  Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.

Authors:  M A Bowman; E H Leiter; M A Atkinson
Journal:  Immunol Today       Date:  1994-03

7.  Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia.

Authors:  S I Harik; J C LaManna
Journal:  J Neurochem       Date:  1988-12       Impact factor: 5.372

8.  Insulin therapy normalizes GLUT1 glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats.

Authors:  A J Lutz; W M Pardridge
Journal:  Metabolism       Date:  1993-08       Impact factor: 8.694

9.  Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus.

Authors:  A L McCall; W R Millington; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
View more
  17 in total

Review 1.  Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.

Authors:  Françoise Roux; Pierre-Olivier Couraud
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Impact of culture media glucose levels on the intestinal uptake of organic cations.

Authors:  Ana Faria; Rosário Monteiro; Diogo Pestana; Fátima Martel; Victor de Freitas; Nuno Mateus; Conceição Calhau
Journal:  Cytotechnology       Date:  2010-03-06       Impact factor: 2.058

Review 3.  Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms.

Authors:  Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew
Journal:  Anesthesiology       Date:  2018-10       Impact factor: 7.892

Review 4.  Remote control of glucose-sensing neurons to analyze glucose metabolism.

Authors:  Alexandra Alvarsson; Sarah A Stanley
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-05-29       Impact factor: 4.310

5.  Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene.

Authors:  K Hosoya; K Tetsuka; K Nagase; M Tomi; S Saeki; S Ohtsuki; H Takanaga; N Yanai; M Obinata; A Kikuchi; T Okano; T Terasaki
Journal:  AAPS PharmSci       Date:  2000

6.  Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM.

Authors:  Janice J Hwang; Lihong Jiang; Muhammad Hamza; Elizabeth Sanchez Rangel; Feng Dai; Renata Belfort-DeAguiar; Lisa Parikh; Brian B Koo; Douglas L Rothman; Graeme Mason; Robert S Sherwin
Journal:  JCI Insight       Date:  2017-10-19

7.  Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS.

Authors:  Fei Du; Yi Zhang; Xiao-Hong Zhu; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

8.  Glycemic Variability and Brain Glucose Levels in Type 1 Diabetes.

Authors:  Janice J Hwang; Lihong Jiang; Elizabeth Sanchez Rangel; Xiaoning Fan; Yuyan Ding; Wai Lam; Jessica Leventhal; Feng Dai; Douglas L Rothman; Graeme F Mason; Robert S Sherwin
Journal:  Diabetes       Date:  2018-10-16       Impact factor: 9.461

9.  Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1 (GLUT1).

Authors:  Meena Garg; Manikkavasagar Thamotharan; Dorothy J Becker; Sherin U Devaskar
Journal:  Pediatr Diabetes       Date:  2014-02-19       Impact factor: 4.866

10.  Intestinal oxidative state can alter nutrient and drug bioavailability.

Authors:  Ana Faria; Rosário Monteiro; Diogo Pestana; Victor de Freitas; Nuno Mateus; Isabel Azevedo; Conceição Calhau
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.